- Page 1 and 2:
ESM European Society of Mycobacteri
- Page 3 and 4:
Welcome Message Dear Colleagues, It
- Page 5 and 6:
Congress Organization EUROPEAN SOCI
- Page 7 and 8:
Program at a glance Sunday, July 5t
- Page 9 and 10:
Wednesday, July 8th 09h00 - 11h00 0
- Page 11 and 12:
Dr. Andre De Bock (BD) Extended Dru
- Page 13 and 14:
16h30 - 16h45 Santos R, Marques M,
- Page 15 and 16:
09h45 - 10h30 10h30 - 10h45 10h45 -
- Page 17 and 18:
Mello FAF, Albarral MIP, Mendes NH,
- Page 19 and 20:
Lima KVB, Lopes ML, Furlaneto IP, L
- Page 21 and 22:
Julián EG, Rodríguez-Güell E, de
- Page 24:
Abstracts of Guest Lectures (GL) Eu
- Page 27 and 28:
GL-2 THE BRAZILIAN EXPERIENCE CONTR
- Page 29 and 30:
GL-3 EVOLUTIONARY FORCES IN Mycobac
- Page 31 and 32:
GL-5 SURROUNDED BY MYCOBACTERIA Jos
- Page 33 and 34:
GL-7 A NOVEL DIAGNOSTIC TEST TO DIF
- Page 35 and 36:
GL-9 REGULATION OF Mycobacterium tu
- Page 37 and 38:
GL-11 DEVELOPMENT AND VALIDATION OF
- Page 39 and 40:
SCREENING OF MOLECULES WITH ANTI-TB
- Page 41 and 42:
GL-15 NEW, EASY-TO-USE TOOLS FOR QU
- Page 44 and 45:
OP-1 Mass Spectrometry for Molecula
- Page 46 and 47:
OP-3 IDENTIFICATION OF THE INSERTIO
- Page 48 and 49:
OP-5 PENITENTIARY POPULATION OF Myc
- Page 50 and 51:
op-7 Mycobacterium tuberculosis gen
- Page 52 and 53:
OP-9 LAM AND HIV: CORRELATION OR CO
- Page 54 and 55:
OP-11 Mycobacterium avium SUBSPECIE
- Page 56 and 57:
OP-13 THE SUNNY SIDE OF MYCOBACTERI
- Page 58 and 59:
OP-15 HOW WILD-TYPE MIC DISTRIBUTIO
- Page 60 and 61:
OP-17 Mycobacterium tuberculosis IS
- Page 62 and 63:
A REPORT ON NEW ADAPTED FORMS OF EX
- Page 64 and 65:
OP-21 PRESENCE OF ESAT-6 AND CFP-10
- Page 66 and 67:
OP-23 TUBERCULOSIS SOFTWARE IN A GE
- Page 68 and 69:
OP-24 Development of an automated c
- Page 70 and 71:
OP-26 THIORIDAZINE SHOWS PROMISING
- Page 72:
OP-28 MEMBRANE- BASED VERSUS MICROB
- Page 76 and 77:
PP-1 EVALUATION OF THE HIGH-THROUGH
- Page 78 and 79:
PP-3 ASSOCIATION BETWEEN BEIJING GE
- Page 80 and 81:
PP-6 SPOLIGOTYPE PATTERNS AND DRUG
- Page 82 and 83:
PP-8 Mycobacterium tuberculosis BEI
- Page 84 and 85:
PP-11 FITNESS STUDY OF THE RD RIO L
- Page 86 and 87:
PP-13 IMPORTANCE OF MOLECULAR TYPIN
- Page 88 and 89:
PP-15 MOLECULAR EPIDEMIOLOGY STUDY
- Page 90 and 91:
SPOLIGOTYPING OF Mycobacterium tube
- Page 92 and 93:
PP-19 MULTIPLY RECURRENT TUBERCULOS
- Page 94 and 95:
PP-21 MOLECULAR STUDY OF RECURRENT
- Page 96 and 97:
GENOTYPING OF MONO AND MULTI-DRUG R
- Page 98 and 99:
PP-25 Drug-resistance of Mycobacter
- Page 100 and 101:
PP-27 Mutational analysis of genes
- Page 102 and 103:
PP-29 CHARACTERISATION OF STREPTOMY
- Page 104 and 105:
PP-31 tuberculosis RESISTANCE in a
- Page 106 and 107:
PP-33 GENOTYPIC DETECTION OF ISONIA
- Page 108 and 109:
PP-35 Mycobacterium tuberculosis: 1
- Page 110 and 111:
PP-37 IN VITRO ACTIVITY OF OFLOXACI
- Page 112 and 113:
DETECTION OF EMBB GENE CODON 306 MU
- Page 114 and 115:
PP-41 Characterization of gidB gene
- Page 116 and 117:
PP-43 DESIGN OF A RAPID METHOD OF I
- Page 118 and 119:
PP-45 Resistance, MDR and XDR of M.
- Page 120 and 121:
PP-47 TYPING OF Mycobacterium avium
- Page 122 and 123:
PP-49 IS1245-RFLP Based Genetic Rel
- Page 124 and 125:
PP-51 Nontuberculous Mycobacteria,
- Page 126 and 127:
PP-53 EVALUATION OF HSP 65, TB ,SP
- Page 128 and 129:
IDENTIFICATION OF NONTUBERCULOUS MY
- Page 130 and 131:
PP-57 ISOLATION AND IDENTIFICATION
- Page 132 and 133:
PP-59 A CASE-REPORT OF Mycobacteriu
- Page 134 and 135:
PP-61 LABORATORY MICROBIOLOGY CONTR
- Page 136 and 137:
TEACHING OLD BONES NEW TRICKS; SING
- Page 138 and 139:
DIRECT IDENTIFICATION OF Mycobacter
- Page 140 and 141:
PP-67 FIRST EXPERIENCE WITH GENOTYP
- Page 142 and 143: PP-69 EVALUATION OF A NEW REAL-TIME
- Page 144 and 145: CLINICAL PERFORMANCE OF QUANTIFERON
- Page 146 and 147: PP-73 QUANTIFERON ® -TB GOLD IN-TU
- Page 148 and 149: REAL-TIME POLYMERASE CHAIN REACTION
- Page 150 and 151: PP-77 DETECTION OF Mycobacterium tu
- Page 152 and 153: PP-79 OSSEOUS TUBERCULOSIS AT AGE O
- Page 154 and 155: PP-81 ROLE OF TNF-a GENE POLYMORPHI
- Page 156 and 157: PP-83 VIRULENCE, IMMUNOGENICITY AND
- Page 158 and 159: PP-85 ANALYSIS OF M. smegmatis MUTA
- Page 160 and 161: PP-87 Mycobacterium tuberculosis Ar
- Page 162 and 163: IMPLEMENTATION OF THE THIN LAYER AG
- Page 164 and 165: PP-91 DIRECT DETECTION OF RIFAMPIN
- Page 166 and 167: PP-93 CONTRIBUTION OF LABORATORY FA
- Page 168 and 169: PP-95 EVALUATION OF CAPILIA (TAUNS)
- Page 170 and 171: PP-97 DIRECT TESTING FOR MULTI DRUG
- Page 172 and 173: PP-99 VARIOUS STRATEGIES TO DECONTA
- Page 174 and 175: PP-101 COMPARISON OF RAPID COLORIME
- Page 176 and 177: PP-103 NITRATE REDUCTASE ASSAY APPL
- Page 178 and 179: PP-105 Implementation of liquid cul
- Page 180 and 181: PP-107 SYNERGISTIC ACTIVITY OF TWO
- Page 182 and 183: PP-109 PREVALENCE OF EFFLUX-MEDIATE
- Page 184 and 185: PP-111 ANTI-MYCOBACTERIUM TUBERCULO
- Page 186 and 187: PP-113 the human macrophage as a mo
- Page 188: PP-115 Nosocomial TB in a laborator
- Page 191: Levterova V Lezcano MA Lima EJC Lim
Change language